However, when a bivariate analysis was undertaken with disease stage as the second parameter, a highly significant contribution of CB 1 IR was seen ( Table 2 ).
← all excerpts
High tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer.
1
—
—